crowman
MuscleHead
- Nov 2, 2011
- 1,229
- 204
New Study Dispels Long-held Myth that Testosterone Replacement Treatment Raises Risk of Prostate Cancer
LifeXMD.com - Dec. 27, 2012 -- The findings of a two year study published online in the Journal Of Sexual Medicine*** http://onlinelibrary.wiley.com/doi/10.1111/j.1743-6109.2012.02808.x/abstract by clinicians from the Andropause Society (The Society for the Study of Androgen Deficiency) has firmly ruled out a long held myth that Testosterone Replacement Therapy (TRT) used to treat Testosterone Deficiency Syndrome (Andropause, Male Menopause, Hypogonadism) may increase a patient’s chance of developing prostate cancer.
Testosterone Deficiency Syndrome (Andropause, Male Menopause, Hypogonadism), a serious condition characterised by depression, weight gain, brain fog, memory loss, irritability, night sweats decreased sex drive, erection problems, loss of energy and associated with heart failure, diabetes, obesity and osteoporosis, is estimated to affect 2 million men over 50* and an undetermined number of younger males.
Research shows only 1% of sufferers have been diagnosed and treated. *
Commenting on the outcome of the new research by Andropause Society trustees, Dr Mark Feneley and Dr Malcolm Carruthers, conducted with 1500 patients, the charity's acting Chief Executive Paul Pennington commented, "It is extremely gratifying to know we can finally remove one of the obstacles that has seemingly prevented the medical profession from treating this common hormonal disturbance in men, which can wreck their lives, loves and health."
He added, "Unfortunately the views about the dangers of TRT are about 20 years out of date. The experience of clinicians working in this important area of men's health has shown that rather than being dangerous, carefully regulated and monitored TRT has been shown to be remarkably safe. This is backed by recent studies showing the medical benefits of testosterone treatment as emphasized by Professor Tom Trinick, from the Department of Chemical Pathology at The Ulster Hospital Belfast and previous Chairman of the Andropause Society, that highlight the benefits of TRT. Evidence shows it reduces obesity, can prevent complications of diabetes, lowers cholesterol and is being used to prevent heart attacks and strokes in diabetics."."
LifeXMD is the leader in comprehensive life-enhancing vitality support. Offering physician-supervised bio-identical hormone replacement as well as a full range of wellness modalities, we can help you defy the effects of aging, meet your fitness goals and get back to full enjoyment of your life. Visit www.LifeXMD.com today for more information or to schedule a No Charge Consultation.
References
**Trinick T.R.,Feneley M.R. Welford H, Carruthers M. Department of Chemical Pathology The Ulster Hospital Belfast, Institute of Urology & Nephrology University College Hospital London, Centre for Men's Health, The Aging Male 2010 1-6 *International web survey shows high prevalence of symptomatic testosterone deficiency in men. July 2010 Informa healthcare.
***The Journal of Sexual Medicine is the Official Journal of the International Society for Sexual Medicine (ISSM). The International Society for Sexual Medicine was founded in 1982 for the purpose of promoting research and exchange of knowledge for the clinical entity 'impotence' throughout the international scientific community. The principal orientation of ISSM was initially towards basic science of erection, defects in the erectile mechanism, and the clinical aspects of diagnosis and treatment of erectile dysfunction. The focus is now towards the whole field of sexual medicine.
LifeXMD.com - Dec. 27, 2012 -- The findings of a two year study published online in the Journal Of Sexual Medicine*** http://onlinelibrary.wiley.com/doi/10.1111/j.1743-6109.2012.02808.x/abstract by clinicians from the Andropause Society (The Society for the Study of Androgen Deficiency) has firmly ruled out a long held myth that Testosterone Replacement Therapy (TRT) used to treat Testosterone Deficiency Syndrome (Andropause, Male Menopause, Hypogonadism) may increase a patient’s chance of developing prostate cancer.
Testosterone Deficiency Syndrome (Andropause, Male Menopause, Hypogonadism), a serious condition characterised by depression, weight gain, brain fog, memory loss, irritability, night sweats decreased sex drive, erection problems, loss of energy and associated with heart failure, diabetes, obesity and osteoporosis, is estimated to affect 2 million men over 50* and an undetermined number of younger males.
Research shows only 1% of sufferers have been diagnosed and treated. *
Commenting on the outcome of the new research by Andropause Society trustees, Dr Mark Feneley and Dr Malcolm Carruthers, conducted with 1500 patients, the charity's acting Chief Executive Paul Pennington commented, "It is extremely gratifying to know we can finally remove one of the obstacles that has seemingly prevented the medical profession from treating this common hormonal disturbance in men, which can wreck their lives, loves and health."
He added, "Unfortunately the views about the dangers of TRT are about 20 years out of date. The experience of clinicians working in this important area of men's health has shown that rather than being dangerous, carefully regulated and monitored TRT has been shown to be remarkably safe. This is backed by recent studies showing the medical benefits of testosterone treatment as emphasized by Professor Tom Trinick, from the Department of Chemical Pathology at The Ulster Hospital Belfast and previous Chairman of the Andropause Society, that highlight the benefits of TRT. Evidence shows it reduces obesity, can prevent complications of diabetes, lowers cholesterol and is being used to prevent heart attacks and strokes in diabetics."."
LifeXMD is the leader in comprehensive life-enhancing vitality support. Offering physician-supervised bio-identical hormone replacement as well as a full range of wellness modalities, we can help you defy the effects of aging, meet your fitness goals and get back to full enjoyment of your life. Visit www.LifeXMD.com today for more information or to schedule a No Charge Consultation.
References
**Trinick T.R.,Feneley M.R. Welford H, Carruthers M. Department of Chemical Pathology The Ulster Hospital Belfast, Institute of Urology & Nephrology University College Hospital London, Centre for Men's Health, The Aging Male 2010 1-6 *International web survey shows high prevalence of symptomatic testosterone deficiency in men. July 2010 Informa healthcare.
***The Journal of Sexual Medicine is the Official Journal of the International Society for Sexual Medicine (ISSM). The International Society for Sexual Medicine was founded in 1982 for the purpose of promoting research and exchange of knowledge for the clinical entity 'impotence' throughout the international scientific community. The principal orientation of ISSM was initially towards basic science of erection, defects in the erectile mechanism, and the clinical aspects of diagnosis and treatment of erectile dysfunction. The focus is now towards the whole field of sexual medicine.